nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adenylate cyclase inhibition is required for normal redistribution of platelet surface GPIb in response to PAR1 activation
|
Pouget, Thomas |
|
2019 |
173 |
C |
p. 151-154 |
artikel |
2 |
A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation
|
Luo, Lili |
|
2019 |
173 |
C |
p. 131-140 |
artikel |
3 |
Anticoagulation during ECMO in neonatal and paediatric patients
|
Barton, Rebecca |
|
2019 |
173 |
C |
p. 172-177 |
artikel |
4 |
Apixaban and rivaroxaban in patients with cerebral venous thrombosis
|
Covut, Fahrettin |
|
2019 |
173 |
C |
p. 77-78 |
artikel |
5 |
Assessment of atrial fibrillation patients' education needs from patient and clinician perspectives: A qualitative descriptive study
|
Salmasi, Shahrzad |
|
2019 |
173 |
C |
p. 109-116 |
artikel |
6 |
Association between insurance status, anticoagulation quality, and clinical outcomes in patients with acute venous thromboembolism
|
Zumbrunn, Brigitta |
|
2019 |
173 |
C |
p. 124-130 |
artikel |
7 |
Bleeding and thrombotic events occur early in children on durable ventricular assist devices
|
Huang, Joanna Y. |
|
2019 |
173 |
C |
p. 65-70 |
artikel |
8 |
Candidate gene and pathway analyses identifying genetic variations associated with prasugrel pharmacokinetics and pharmacodynamics
|
Liu, Zhiyan |
|
2019 |
173 |
C |
p. 27-34 |
artikel |
9 |
Clinical outcomes in hemophilia A patients undergoing tailoring of prophylaxis based on population-based pharmacokinetic dosing
|
Nagao, Azusa |
|
2019 |
173 |
C |
p. 79-84 |
artikel |
10 |
Comparison of three routes of administration of tranexamic acid in primary unilateral total knee arthroplasty: Analysis of a national database
|
Xie, Jinwei |
|
2019 |
173 |
C |
p. 96-101 |
artikel |
11 |
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
|
Li, Ang |
|
2019 |
173 |
C |
p. 158-163 |
artikel |
12 |
Direct oral anticoagulants: What will be their role in children?
|
Male, Christoph |
|
2019 |
173 |
C |
p. 178-185 |
artikel |
13 |
Editorial Board
|
|
|
2019 |
173 |
C |
p. IFC |
artikel |
14 |
Effect of low and moderate dose FEIBA to reverse major bleeding in patients on direct oral anticoagulants
|
Dager, W.E. |
|
2019 |
173 |
C |
p. 71-76 |
artikel |
15 |
Effect of P2Y12 inhibitors on thrombus stability and endogenous fibrinolysis
|
Spinthakis, Nikolaos |
|
2019 |
173 |
C |
p. 102-108 |
artikel |
16 |
Elastic compression stockings one year after DVT diagnosis: Who might discontinue?
|
Mol, G.C. |
|
2019 |
173 |
C |
p. 35-41 |
artikel |
17 |
Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation
|
Mørk, Morten |
|
2019 |
173 |
C |
p. 141-150 |
artikel |
18 |
Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study
|
Mei, Heng |
|
2019 |
173 |
C |
p. 20-26 |
artikel |
19 |
Family history of venous thromboembolism in the paediatric population: The need for a standardized definition
|
Hau, Anna |
|
2019 |
173 |
C |
p. 91-95 |
artikel |
20 |
Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis
|
Barco, Stefano |
|
2019 |
173 |
C |
p. 166-171 |
artikel |
21 |
Incidence, risk factors, and outcomes of venous thromboembolism after oncologic surgery: A systematic review and meta-analysis
|
Li, Mao |
|
2019 |
173 |
C |
p. 48-56 |
artikel |
22 |
Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission
|
Di Pasquale, Irene |
|
2019 |
173 |
C |
p. 42-47 |
artikel |
23 |
Low-molecular weight heparin or direct oral anticoagulants for the treatment of cancer associated thrombosis. Are we at the crossroad?
|
Meyer, Guy |
|
2019 |
173 |
C |
p. 156-157 |
artikel |
24 |
Presence of thrombophilia and levels of coagulation factors, coagulation inhibitors and TAFI do not affect global haemostasis or bleeding phenotype in patients with haemophilia A
|
Mikovic, Danijela |
|
2019 |
173 |
C |
p. 1-3 |
artikel |
25 |
Sex may matter when it comes to the presenting location of deep vein thrombosis
|
Tagalakis, Vicky |
|
2019 |
173 |
C |
p. 164-165 |
artikel |
26 |
Slow progress. How do we shift the paradigm of thinking in pediatric thrombosis and anticoagulation?
|
Monagle, Paul |
|
2019 |
173 |
C |
p. 186-190 |
artikel |
27 |
Systemic thrombolysis in haemodynamically unstable pulmonary embolism: The earlier the better?
|
Zuin, Marco |
|
2019 |
173 |
C |
p. 117-123 |
artikel |
28 |
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies
|
Ferrarese, Mattia |
|
2019 |
173 |
C |
p. 4-11 |
artikel |
29 |
The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications
|
Kovac, Mirjana |
|
2019 |
173 |
C |
p. 12-19 |
artikel |
30 |
The prognosis of disseminated intravascular coagulation associated with hematologic malignancy and its response to recombinant human thrombomodulin
|
Kurita, Naoki |
|
2019 |
173 |
C |
p. 57-64 |
artikel |
31 |
Understudied Areas
|
|
|
2019 |
173 |
C |
p. 155 |
artikel |
32 |
Women's views, adherence and experience with postnatal thromboprophylaxis
|
Guimicheva, Boriana |
|
2019 |
173 |
C |
p. 85-90 |
artikel |